Tenet Healthcare Corporation (THC)
Should Value Investors Buy Tenet Healthcare (THC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Fast-paced Momentum Stock Tenet (THC) Is Still Trading at a Bargain
Tenet (THC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Why Tenet Healthcare (THC) Outpaced the Stock Market Today
The latest trading day saw Tenet Healthcare (THC) settling at $154.62, representing a +0.91% change from its previous close.
Tenet Healthcare Corporation (THC) Hit a 52 Week High, Can the Run Continue?
Tenet (THC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Are Investors Undervaluing Tenet Healthcare (THC) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Tenet Healthcare: Strong EPS Growth, But Shares Near FV (Rating Downgrade)
Health Care stocks, particularly Eli Lilly, have surged recently, with Tenet Healthcare (THC) also performing well post-COVID, but now near intrinsic value. Despite strong earnings and high free cash flow, I downgrade THC from buy to hold due to its fair valuation and potential mean reversion. THC's growth in ambulatory surgery centers and shareholder rewards are positives, but risks include high-interest rates, regulatory issues, and a high P/E ratio.
Tenet Stock Rises 24.6% in 3 Months: Is This Your Buy Signal?
Despite the recent growth in stock price, THC is trading at a discount compared to the industry average.
Why Tenet Healthcare (THC) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Tenet Healthcare (THC) is a Top-Ranked Growth Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Brokers Suggest Investing in Tenet (THC): Read This Before Placing a Bet
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?
Why Is Tenet (THC) Up 7.2% Since Last Earnings Report?
Tenet (THC) reported earnings 30 days ago. What's next for the stock?
